Health and Fitness
Health and Fitness
Mon, January 20, 2025
[ 05:43 PM ] - Indiatimes
[ 04:23 PM ] - MSN
[ 03:23 PM ] - MSN
[ 02:23 PM ] - MSN
[ 02:03 PM ] - MSN
[ 02:03 PM ] - MSN
[ 01:43 PM ] - MSN
[ 01:43 PM ] - MSN
[ 12:43 PM ] - Indiatimes
[ 11:43 AM ] - MSN
[ 11:43 AM ] - MSN
[ 11:03 AM ] - Indiatimes
How GLP-1 drugs like Ozempic and Wegovy affect risk of 175 conditions
- The benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an assessment of how the drugs affect 175 conditions
The article from MSN discusses the impact of GLP-1 drugs like Ozempic and Wegovy on the risk of developing 175 different health conditions. These medications, originally developed for managing type 2 diabetes, have shown significant benefits beyond just weight loss. According to a comprehensive study, GLP-1 agonists reduce the risk of numerous health issues including heart disease, kidney disease, and various obesity-related conditions. Specifically, they lower the risk of heart failure by 20%, kidney disease by 24%, and even decrease the likelihood of developing conditions like sleep apnea, gout, and liver disease. However, the drugs also come with side effects like nausea and potential risks like thyroid cancer, though the latter is less common. The study highlights the broad protective effects of these drugs, suggesting they could play a crucial role in preventive healthcare for a wide array of conditions linked to obesity and metabolic syndrome.
Read the Full MSN Article at:
[ https://www.msn.com/en-us/health/diseases-and-conditions/how-glp-1-drugs-like-ozempic-and-wegovy-affect-risk-of-175-conditions/ar-AA1xwL2v ]
Read the Full MSN Article at:
[ https://www.msn.com/en-us/health/diseases-and-conditions/how-glp-1-drugs-like-ozempic-and-wegovy-affect-risk-of-175-conditions/ar-AA1xwL2v ]
Contributing Sources
Similar Health and Fitness Articles
[ 02:03 PM ] - Today